# Study of Acamprosate in Fragile x Syndrome

> **NCT01911455** · PHASE1 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 46 (actual)

## Conditions studied

- Fragile X Syndrome

## Interventions

- **DRUG:** acamprosate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01911455
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-27
- **Primary completion:** 2018-11-08
- **Final completion:** 2018-11-08
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2021-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01911455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01911455, "Study of Acamprosate in Fragile x Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01911455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*